Skip to content

Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer

Endoscopic Surveillance Comparing Narrow Band Imaging (NBI) Against Lugol Chromoendoscopy for Detection of Synchronous Superficial Squamous Esophageal Neoplasia Among High Risk Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02002559
Enrollment
180
Registered
2013-12-06
Start date
2006-04-30
Completion date
2010-12-31
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial Esophageal Neoplasia

Brief summary

This study aimed to compare Narrow Band Imaging (NBI) against Lugol chromoendoscopy for diagnosis of early esophageal cancers among high risk patients.

Detailed description

The investigators recruited consecutive patients with head and neck cancers, history of squamous esophageal cancers treated by chemoradiotherapy or endoscopic resection. Endoscopic surveillance first started with NBI for detection and characterization of early esophageal cancers through observation of abnormal intrapapillary capillary loops (IPCL). Superficial esophageal neoplasia were diagnosed by IPCL Type IV, V1,V2 and Vn. Lugol chromoendoscopy would be performed subsequently and suspicious neoplasia were classified as understain or unstain lesions. The diagnostic accuracy, sensitivity and specificity of NBI were compared to Lugol chromoendoscopy with histology serving as a gold standard.

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with Head and Neck Cancer 2. Patients with esophageal cancer treated by chemoradiotherapy and in remission for 2 years 3. Patients with esophageal cancer treated by endoscopic resection 4. Age 18 to 80

Exclusion criteria

1. Allergy to Lugol iodine 2. Pregnancy 3. Previous esophagectomy

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of superficial esophageal neoplasia1 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026